« Previous
Next »
Journal of Neuroimmunology
Volume 215, Issue 1
, Pages 31-35
, 30 October 2009
Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study
References
- . Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Mult. Scler. 2008;14:48–51
- . Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007;69:2221–2231
- . Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J. Exp. Med. 2008;205:2473–2481
- . Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008;131:3072–3080
- . Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. NeuroReport. 2009;20:508–512
- . Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ. 2009;16:3–11
- . Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology. 2006;67:176–177
- . A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112
- . IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 2005;202:473–477
- . A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125:1450–1461
- . Interplay of leukemia inhibitory factor and retinoic acid on neural differentiation of mouse embryonic stem cells. J. Neurosci. Res. 2007;85:2686–2701
- . NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008;70:2179–2200
- . Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell. Bio. 1980;85:890–902
- . Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001;50:121–127
- . Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007;130:1224–1234
- . Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130:1194–1205
- . Revised diagnostic criteria for neuromyelitis optica (NMO): application in a series of suspected patients. J. Neurol. 2007;254:1233–1237
- . Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood–brain barrier permeability and granulocyte recruitment. J. Immunol. 2008;181:5730–5737
- . Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int. MS J. 2008;15:99–105
- . Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch. Neurol. 2008;65:913–919
- . Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 2006;59:566–569
- . GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. J. Neurosci. 2000;20:7307–7316
- . Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–1489
PII: S0165-5728(09)00296-3
doi: 10.1016/j.jneuroim.2009.07.014
© 2009 Elsevier B.V. All rights reserved.
« Previous
Next »
Journal of Neuroimmunology
Volume 215, Issue 1
, Pages 31-35
, 30 October 2009
